返回产品
威格顿生物 徐州威格顿生物科技有限公司
威格顿生物
威格顿生物 Weigedun Biotechnology
产品说明书

IL6ST Mouse mAb

货号WGD-Z-2611363 更新日期2026-09-03
规格信息
规格货号
50ul WGD-Z-2611363
100ul WGD-Z-2611363
详细参数
别名 Interleukin-6 receptor subunit beta; IL-6 receptor subunit beta; IL-6R subunit beta; IL-6R-beta; IL-6RB; CDw130; Interleukin-6 signal transducer; Membrane glycoprotein 130; gp130; Oncostatin-M receptor subunit alpha; CD antigen CD130
基因名 IL6ST
UniProt ID P40189
反应种属 Human
应用 WB
宿主 Mouse
偶联物 Unconjugated
修饰 Unmodified
亚型 IgG1
克隆号 3B2-E3-O9
克隆性 Monoclonal Antibody
分子量 Calculated MW: 103 kDa
纯化方式 Affinity Purified
产品形式 Liquid
推荐稀释比 WB-1:1000
存储缓冲液 Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide
保存温度 Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
背景信息 Interleukin 6 cytokine family signal transducer (IL6ST), also known as gp130, is the shared signaling subunit for the interleukin-6 (IL-6) family of cytokines. It mediates diverse physiological processes, including immune responses, hematopoiesis, and bone metabolism. The receptor consists of an extracellular region with cytokine-binding domains and a cytoplasmic tail that, while lacking intrinsic kinase activity, associates with JAK/STAT, Ras/Raf, and Src-family kinases upon ligand-induced homodimerization. Signaling is initiated when IL-6 binds to IL-6Rα, followed by the recruitment of gp130 to form a high-affinity hexameric complex. Clinically, dysregulation of the IL-6/IL6ST axis is central to the pathogenesis of rheumatoid arthritis, Castleman disease, and cytokine release syndrome. Therapeutic inhibitors targeting this axis are widely used to manage these inflammatory conditions.